Table 3.
Frequent Exacerbators (n = 9) | Infrequent Exacerbations (n = 7) | P Value | |
---|---|---|---|
Age, yr | 77 (72.5–82) | 67 (63.5–71) | 0.29 |
GOLD stage | |||
2 | 1 (11.1%) | 1 (14.3%) | 1.0 |
3 | 8 (88.9%) | 6 (85.7%) | 1.0 |
Male sex | 6 (66.7%) | 3 (42.9%) | 0.61 |
Inhaled corticosteroid use | 7 (77.8%) | 3 (42.9% | 0.30 |
Long-acting β-agonist use | 7 (77.8%) | 3 (42.9%) | 0.30 |
Antimuscarinic inhaler use | 7 (77.8%) | 3 (42.9%) | 0.30 |
Current smoker | 1 (11.1%) | 3 (42.9%) | 0.26 |
COPD, chronic obstructive pulmonary disease; GOLD, Global Initiative for Obstructive Lung Disease.